Dr. Yuan-Hong Gao is a professor of radiation oncology of Sun Yat-sen University Cancer Center. Dr. Gao obtained his Bachelor in Medicine (equivalent to MD in the US) at Jiangxi Medical College and a PhD at Peking Union Medical College, P. R. China in 1991 and 2002, respectively. His postdoctoral training at Baylor College of Medicine provided him with great opportunities to explore the fields of molecular target therapy and radio sensitivity from 2006 to 2008.

He joined the Department of Radiation Oncology of the Sun Yat-sen University Cancer Center (SYSUCC) as an attending physician in July 2002, he then became a vice-professor in 2006, and finally a Professor in 2013. Dr. Gao has been well trained both in the fields of clinical treatment and cancer research, especially for the fields colorectal cancer, nasopharyngeal carcinoma and pediatric tumors. Dr. Gao has published more than 50 research papers.

Clinical and basic research on colorectal cancer

Sep. 2006-Jun. 2008 Baylor College of Medicine Post-Doc 

Sep. 1997-Jun. 2002 Peking Union Medical College Ph.D. 

Sep. 1986-Jun. 1991 Jiangxi Medical College MD.

1) Yuan-Hong Gao, Jun-Zhong Lin, Xin An, Jie-Lin Luo，Mu-Yan Cai, Pei-Qiang Cai, Ling-Heng Kong, Guo-Chen Liu, Jing-Hua Tang, Gong Chen, Zhi-Zhong Pan, Pei-Rong Ding.Neoadjuvant Sandwich Treatment With Oxaliplatin and Capecitabine Administered Prior to, Concurrently with, and Following Radiotherapy in Locally Advanced Rectal Cancer：A Prospective Phase II Trial. Int J Radiat Oncol Biol Phys. 2014.（Article accepted for publication: 14-JUL-2014）（IF：4.176）

2) Kai-Yun You, Rong Huang,Yuanhong Gao（correspondence）.Adjuvant chemotherapy for rectal cancer. Lancet Oncol.2014, 15(6): e194. （correspondence）（IF 25.117）

3) Kai-Yun You,Yuanhong Gao（correspondence）. Can tumor location predict effectiveness of Bevacizumab conducted in the first-line setting for metastatic colorectal cancer. Ann Oncol. 2014, 25(2):545-546. （correspondence）（IF：7.384）

4) Kai-Yun You,Yuanhong Gao（correspondence）. Can Quantified pathologic response assessed as residual tumor burden be a promising stage system for rectal cancer treated with chemoradiation followed by surgery? Cancer. 2014 120(8):1281-2. （correspondence）（IF：5.201）

5) Gao YH, Zhang X, An X, Cai MY, Zeng ZF, Chen G, Kong LH, Lin JZ, Wan DS, Pan ZZ,Ding PR,et al. Oxaliplatin and capecitabine administered concomitant to neoadjuvant radiotherapy and extended to the resting period in high risk locally advanced rectal cancer. Strahlentherapie und Onkologie. 2014, 190(2): 158-164. IF: 4.163 ）

6) Kai-yun You, Rong Huang, Pei-rong Ding, Bo Qiu, Guan-qun Zhou, Hui Chang, Wei-wei Xiao, Zhi-fan Zeng, Zhi-zhong Pan, Yuan-hong Gao（correspondence）. Selective use of adjuvant chemotherapy for rectal cancer patients with ypN0. Int J Colorectal Dis. 2014, 29(4): 529-538 （IF：2.385）

7) Gao YH, An X, Sun WJ, Cai J, Cai MY, Kong LH, Lin JZ, Liu GC, Tang JH, Wu XJ, Chen G, Pan ZZ, Ding PR. Evaluation of capecitabine and oxaliplatin administered prior to and then concomitant to radiotherapy in high risk locally advanced rectal cancer . J Surg Oncol. 2014, 109(5):478-82 （IF：2.644）

8) Hai-Hua Peng, Kai-Yun You, Cheng-Tao Wang, Rong Huang, Hong-Bo Shan, Jian-Hua Zhou, Xiao-Qing Pei, Yuan-Hong Gao（correspondence）, Bi-Xiu Wen，Meng-Zhong Liu. Value of transrectal ultrasonography for tumor node metastasis restaging in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy . Gastroenterology Report. 2013,1：186-192

9) Gao Y, Ishiyama H, Sun M, Brinkman KL, Wang X, Zhu J, Mai W, Huang Y, Floryk D, Ittmann M, Thompson TC, Butler EB, Xu B, Teh BS. The alkylphospholipid, perifosine, radiosensitizes prostate cancer cells both in vitro and in vivo. Radiat Oncol. 2011. 6: 39-44. (IF: 2.381)Rao B, Gao Y (co-author), Huang J, Gao X, Fu X, Huang M, Yao J, Wang J, Li W, Zhang J, Liu H, Wang L, Wang J.Mutations of p53 and K-ras correlate TF expression in human colorectal carcinomas: TF downregulation as a marker of poor prognosis. Int J Colorectal Dis. 2011. 26(5): 593-601. (IF: 2.415 )

10) Ren YF, Gao YH (co-author), Cao XP, Ye WJ, Teh BS.3D-CT implanted interstitial brachytherapy for T2b nasopharyngeal carcinoma. Radiat Oncol. 2010. 5: 113-116. (IF: 2.381)

11) Y. Gao, X. Wang, J. Zhu, W. Mai, Y. Huang, D. Floryk, M. Ittmann, T. Thompson, E.B. Butler, B.S. Teh. Combined Perifosine (PI3K/AKT Inhibitor) and Radiotherapy for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2008; 72(1): S712-S713.

12) Rao B, Gao Y, Zhou Q, Xiao P, Xia S, Ma J, Luo J, Xiao T, Le S, Huang M, Wang J. A recombinant adenovirus vector encoding the light chain of human coagulation factor VII and IgG1 Fc fragment to targeting tissue factor for colorectal cancer immunotherapy in the mouse model. J Cancer Res Clin Oncol. 2013, 139(6):1015-23. (IF: 3.009)

13) Pei-Rong Ding, Yuan-Hong Gao, Xin An, Gong Chen, Feng-Hua Wang, Mu-Yan Cai, Zhi-Fan Zeng, Ling-Heng Kong, Jun-Zhong Lin, Xiaojun Wu, Zhen-Hai Lu, Li-Ren Li,De-Sen Wan and Zhi-Zhong Pan. Oxaliplatin and capecitabine initially concomitant to radiotherapy then administered in the resting period in highrisk locally advanced rectal cancer. JCO. 2013. 31(4): 581. (Abstract) (IF: 17.879)

14) Yu-Feng Ren, Xin-Ping Cao, Jia Xu, Wei-Jun Ye, Yuan-Hong Gao, Bin S Teh and Bi-Xiu Wen. 3D-image-guided high-dose-rate intracavitary brachytherapy for salvage treatment of locally persistent nasopharyngeal carcinoma. Radiation Oncology. 2013,2013, 8:165

15) Hui Z, Tretiakova M, Zhang Z, Li Y, Wang X, Zhu JX, Gao Y, Mai W, Furge K, Qian CN, Amato R, Butler EB, Teh BT, Teh BS. Radiosensitization by inhibiting STAT1 in renal cell carcinoma.Int J Radiat Oncol Biol Phys. 2009 Jan 1; 73(1): 288-295.

16) Wu SX, Chua DT, Deng ML, Zhao C, Li FY, Sham JS, Wang HY, Bao Y, Gao YH, Zeng ZF. 90 patients with locally persistent and recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2007, 69(3): 761-769. 

17) Xiao Lin, Deng Wenjing, Huang Rong, Zhou Guanqun, Xiao Weiwei, Chen Li, Qiu Bo, Chang Hui, Gao Yuanhong（correspondence）, Liu Mengzhong. Distribution of residual cancer cells in bowel wall and its associated factors in patients with rectal cancer after preoperative VMAT with concurrent chemotherapy. Chinese Journal of Radiation Oncology，2014, 23(3):210-214

18) Xiao Lin, Huang Rong, You Kaiyun, Chen Li, Chang Hui, Zhou Guanqun, Qiu Bo, Xiao Weiwei, Gao Yuanhong（correspondence）, Liu Mengzhong. Study on feasibility of preoperative neoadjuvant chemoradiotherapy based on volumetric modulated arc therapy for locally advanced rectal cancer. Chinese Journal of Radiation Oncology，2014, 23(1): 9-13.

19) Xiao Lin, Huang Rong, You Kaiyun, Chang Hui, Qiu Bo, Xiao Weiwei, Gao Yuanhong（correspondence）, Liu Mengzhong. Feasibility study on Xelox (capecitabine plus oxapliplatin) in the volumetric modulated arc therapy (VMAT)-based preoperative chemoradiotherapy for locally advanced rectal cancer. Chin J Gastrointest Surg, 2014, 17(3): 219-224 .

20) Xiao Lin, Gao Yuanhong（correspondence）, Liu Mengzhong. Advances in new chemotherapeutic drugs for preoperative chemoradiation of locally advanced rectal cancer. Chin J Gastrointest Surg, 2014, 17(1): 93-97.

21) PENG Hai-hua, YOU Kai-yun, WANG Cheng-tao, HUANG Rong, CHANG Hui, ZHOU Guan-qun, ZENG Zhi-fan, LIU Meng-zhong, WEN Bi-xiu, GAO Yuan-hong（correspondence）. Prognostic effects of pathological stages in patients with locally advanced rectal cancer after neoadjuvant radiochemotherapy plus radical surgery. Chinese Journal of Radiation Oncology，2013, 22（6）:439-442.

22) PENG Hai-hua, YOU Kai-yun, WANG Cheng-tao, HUANG Rong, Shan Hongbo，Zhuo Jianhua，Pei Xiaoqin，WEN Bi-xiu, LIU Meng-zhong, GAO Yuan-hong（correspondence）。Value of transrectal ultrasonography for tumor node metastasis restaging in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy. .Chin J Gastrointest Surg, 2013, 16（12）:1203-1207.

23) PENG Hai-hua, YOU Kai-yun, GAO Yuan-hong(correspondence), CHEN Li, DU Le-hui, CHEN Lei, ZHOU Guan-qun, ZENG Zhi-fan, WEN Bi-xiu, GAO Yuan-hong Value of postoperative adjuvant chemotherapy in locally advanced rectal cancer patients achieving pathologically complete response after operation following concurrent three-dimensional conformal radiotherapy and chemotherapy. Chinese Journal of Radiation Oncology. 2013, 22(1): 5-8.

24) You Kai-yun, Peng Hai-hua, GAO Yuan-hong (correspondence)，et al. Value of postoperative adjuvant chemotherapy in locally advanced rectal cancer patients with ypT1-4N0 after neo-adjuvant chemoradiotherapy. Chinese Journal of Oncology. 2013，35（9）：707-713

25) Zheng Xues-ong，Han Ning, Kuang Lu, Huang Guan-gyu, GAO Yuan-hong（correspondence）. Typical WAGR Syndrome: A Case Report. Chin J Pediatr, 2013，51（3）：237-239.

26) Ye Xu-juang, GAO Yuan-hong (correspondence), Chen Li, Du Le-Hui, Zhang Guang-shun, Jia Yu-ming, Lei Kai-jian, Liu Meng-zhong. Dosimetric comparison between preoperative five-field intensity modulated radiotherapy and volumetric modulated arc therapy in the treatment of rectum cancer. Chinese Clinical Oncology. 2012. 17（8）：717-720.

27) XU Tao, GAO Yuan-hong（correspondence）, Chen Ping, Wen Ge, Du Le-hui, CAO Feng-jung, JING Hong-Xia, LIU Meng-zhong. An analysis of the combined treatment model for Wilms’ tumor. Chin J Urol. 2012，33（3）：180-184.

28) WAGN Juan, ZHEN Zi-Jun, LIU Jun-cheng, LIU Zhuo-wei, ZHU Jia, CAI Yue, LING Jia-yu, CHEN Yan, CAI Rui-qing, SUN Xiao-fei, GAO Yuan-hong（correspondence）. The value of primary site radiotherapy in stage Ⅳ high-risk neuroblastoma. Chinese Journal of Radiation Oncology. 2012, 21(1): 13-15.

29) Ye Xu-juang, GAO Yuan-hong (correspondence), LIU Bing-ti, CHEN Li, DU LE-hue, ZENG ZHI-fan, ZHANG Guang-sun, Jia Yu-ming, Lei Kai-jian, Liu Meng-zhong. Dosimetric study of 3D conformal radiotherapy compared with 5F intensity modulated radiotherapy in preoperative rectal cancer. CHIN J CANCER PREV TREAT. 2012，19（1）：19-23.

30) Yang Yong, GAO Yuan-hong（correspondence）, Liu Bing-ti, Zhang Yu-jing, Du Lei-hue, Liu Hui, Liu Meng-zhong. A Clinical analysis of 54 cases of esthesioneuroblastoma. Journal of SUN YAT-SEN UNIVERSITY（MEDICAL SCIENCES）. 2011. 32 (4): 553-556.

31) XU Tao, GAO Yuan-hong（correspondence）, Chen Ping, Wen Ge, Du Le-hui, CAO Feng-jung, JING Hong-Xia, LIU Meng-zhong. Clinical analysis of 6 cases of primary small cell carcinoma of the larynx. Chin J Otorhinolaryngol Head Neck Srug，2011, 46（9）：758-760.

32) Yang Yong, GAO Yuan-hong（correspondence），Zhang Yu-jing, Gu Mu-fa, Liu Hui, Hu Wei-han, Wu Shao-xiong, Xia Yun-fei, Liu Meng-zhong. A Clinical analysis of 54 cases of esthesioneuroblastoma. Chinese Journal of Radiation Oncology. 2011. 20（2）：94-95. 

33) XU Tao, GAO Yuan-hong（correspondence）, Chen Ping, Wen Ge, Du Le-hui, CAO Feng-jung, JING Hong-Xia, LIU Meng-zhong. Clinical analysis of 6 cases of pulmonary blastoma. Cance Research on Prevention and Treatment. 2011.38（10）：1214-1216.

 

Last Updated on: August 2014 by International Office, Sun Yat-sen University Cancer Center